Jakowatz, James G

TitleHealth Sciences Professor
InstitutionUniversity of California, Irvine
Address1001 Health Sciences Road
CA 92697-3950
Phone(714) 456-8000
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yue L, Huang ZM, Fong S, Leong S, Jakowatz J, Charruyer-Reinwald A, Wei M, Ghadially R. Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma. Melanoma Res. 2015 Apr; 25(2):138-48. PMID: 25643237.
      View in: PubMed
    2. Linden KG, Leachman SA, Zager JS, Jakowatz J, Viner JL, McLaren CE, Barr RJ, Carpenter PM, Chen WP, Elmets CA, Tangrea JA, Lim SJ, Cochran AJ, Meyskens FL. A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology. Cancer Prev Res (Phila). 2014 May; 7(5):496-504. PMID: 24614012; PMCID: PMC4208700.
    3. Eroglu Z, Kong KM, Jakowatz J, Samlowski W, Fruehauf JP. Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma. Cancer Chemother Pharmacol. 2011 Oct; 68(4):1081-7. PMID: 21769667; PMCID: PMC3180631.
    4. Lane K, Kempf A, Magno C, Lane J, Butler J, Hsiang D, Greenfield S, Jakowatz J. Regional differences in the use of sentinel lymph node biopsy for melanoma: a potential quality measure. Am Surg. 2008 Oct; 74(10):981-4. PMID: 18942627.
      View in: PubMed
    5. Mitchell MS, Abrams J, Thompson JA, Kashani-Sabet M, DeConti RC, Hwu WJ, Atkins MB, Whitman E, Ernstoff MS, Haluska FG, Jakowatz J, Das Gupta TK, Richards JM, Samlowski WE, Costanzi JJ, Aronson FR, Deisseroth AB, Dudek AZ, Jones VE. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma. J Clin Oncol. 2007 May 20; 25(15):2078-85. PMID: 17513813.
      View in: PubMed
    6. Wong SF, Jakowatz J, Taheri R. Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma. Clin Ther. 2005 Dec; 27(12):1942-8. PMID: 16507380.
      View in: PubMed
    7. Fruehauf JP, Kong KM, Jakowatz J. Docetaxel and vinorelbine plus GM-CSF in malignant melanoma. Oncology (Williston Park). 2005 Apr; 19(4 Suppl 2):19-22. PMID: 15934496.
      View in: PubMed
    8. Wong SF, Jakowatz J, Taheri R. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma. Ann Pharmacother. 2004 Oct; 38(10):1655-9. PMID: 15304625.
      View in: PubMed
    9. Cole MD, Jakowatz J, Evans GR. Evaluation of nodal patterns for melanoma of the ear. Plast Reconstr Surg. 2003 Jul; 112(1):50-6. PMID: 12832876.
      View in: PubMed
    10. Chorny JA, Barr RJ, Kyshtoobayeva A, Jakowatz J, Reed RJ. Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions. Mod Pathol. 2003 Jun; 16(6):525-9. PMID: 12808056.
      View in: PubMed
    11. Badgwell BD, Valentino DJ, Jeffes EB, Dieffenbach K, Dulkanchainun SB, Yamamoto RS, Granger GA, Jakowatz J, Carson WE. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunol Immunother. 2003 Jan; 52(1):10-6. PMID: 12536235.
      View in: PubMed
    12. Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz J, Noyes RD, Flaherty LE. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group. J Clin Oncol. 2002 Apr 15; 20(8):2058-66. PMID: 11956266.
      View in: PubMed